NYSE · Medical - Care Facilities
Ardent Health, Inc. (ARDT) Stock
$11.30
+2.08%
NYSE: ARDT
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
UnitedHealth to Top Second-Quarter Earnings Views on Favorable Utilization Trends, Morgan Stanley Says
MT Newswires · Jun 30, 2026
Do Options Traders Know Something About Ardent Health Stock We Don't?
Zacks · Jun 29, 2026
Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares?
Motley Fool · Jun 12, 2026
Spotlight On Undervalued Small Caps With Insider Activity In June 2026
Simply Wall St. · Jun 10, 2026
Will Ardent Health’s (ARDT) New CEO Shift the Focus of Its Post-IPO Efficiency Narrative?
Simply Wall St. · Jun 7, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Ardent Health, Inc.
Ardent Health, Inc. is led by CEO Martin J. Bonick, employs 19,200 people, headquartered in US, publicly traded since 2024.
Ardent Health, Inc. (ARDT) stock trades at $11.30 with a market capitalization of $1.62B. The stock is valued at a price-to-earnings (P/E) ratio of 18.80, price-to-book of 1.08, price-to-sales of 0.23. Over the past 52 weeks the stock has ranged between $7.71 and $15.48, and currently trades 27.0% below its 52-week high.
On profitability, Ardent Health, Inc. generates a return on equity (ROE) of 5.21%, return on capital employed of 11.23%, an operating margin of 5.15%, a net profit margin of 1.22%.